The straight answer
Let's be straight with you: no peptide sold online is a proven treatment for Crohn's disease or ulcerative colitis. A few compounds calm gut inflammation in mice, and that research is genuinely interesting, but "works in mice" is a long way from "safe and effective in a person with IBD." None of these has ever completed a real human trial for your condition, so nothing here should be treated as a therapy, and nothing here should take the place of care that actually controls this disease.
What actually treats it
IBD has real, effective treatments today: anti-inflammatory drugs and steroids for flares, plus modern biologics and small molecules that target the immune signals driving the disease (anti-TNF like infliximab and adalimumab, anti-integrin vedolizumab, anti-IL-23 mirikizumab and ustekinumab, and JAK inhibitors). Started early and matched to your disease by a gastroenterologist, these can put IBD into lasting remission and prevent damage, hospitalizations, and surgery.
From our library
Compounds here with any tie to ibd (crohn's & colitis) — rated honestly for this specific use.
- Early
KPV
SpeculativeKPV is the most gut-relevant peptide in our library. It's a tiny anti-inflammatory fragment of a natural hormone, and across more than a dozen labs over 25 years it has consistently calmed colitis in mice and rats. That's a real, repeatable animal signal for exactly this disease. But there is not one human trial, no established dose, and no human safety data, so it's a compound to watch, not a treatment to use.
- Early
BPC-157
SpeculativeBPC-157 was first studied as a gut-protecting compound and heals the intestinal lining against ulcers and damage in animals. Old review articles even mention an early human ulcerative colitis trial of a related form (PL 14736), but no results or dosing survive in the evidence we can see. The real human data we do have is for knee and bladder pain, not IBD. Promising biology, unproven for your condition.
- Early
VIP
SpeculativeVIP is one of the body's own signals for calming an overactive immune system and protecting the gut lining, and it reduces intestinal inflammation in mouse studies. But it's destroyed in the bloodstream within minutes, has no established human dose, and at sustained high levels it actually causes a serious disease of severe watery diarrhea. It belongs firmly in the research lab, not in a self-treatment plan for IBD.
- Early
LL-37
Not reallyLL-37 is a natural germ-fighting peptide that turns up in inflammation research, so it gets mentioned around gut disease. But it has never been dosed as a treatment in any human, and it can actually amplify autoimmune inflammation. For an immune-driven disease like IBD that's a reason for caution, not hope.
Also being studied (not in our library)
- Teduglutide (GLP-2 analog, brand Gattex/Revestive) — A real, approved peptide drug that helps the gut lining grow and absorb nutrients. It's approved for short bowel syndrome (sometimes a complication of Crohn's) and has been studied for healing the Crohn's gut lining. It's a prescription medicine given under specialist care, not a research peptide you buy online.
- Larazotide (AT-1001) — A gut-barrier ("tight junction") peptide best known from celiac disease trials. It's sometimes discussed for repairing the leaky gut lining in IBD, but its large trials were in celiac and it isn't a proven IBD treatment.
Bottom line
The honest answer is that no peptide here is a proven treatment for Crohn's or colitis, and a couple of them (like LL-37) could even work against you. KPV and BPC-157 are worth keeping an eye on as research matures, but today they are experiments, not medicine.